drugset / Trial / NCT00800722
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Phase 1
Completed
21 enrolled
University of California, Irvine
Beckman Laser Institute University of California Irvine · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researchers want to determine whether the combined use of pulsed dye laser therapy and rapamycin will improve PWS therapeutic outcome.
Timeline
- Start
- 2008-11
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | — | — |